Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Pharmacyclics

AbbVie CEO Gonzalez defends Allergan takeover

AbbVie CEO Gonzalez defends Allergan takeover

including a $21bn takeover of Pharmacyclics and $9.8bn deal for Stemcentrx.

AbbVie to acquire Allergan for $63bn

AbbVie to acquire Allergan for $63bn Analysts have not been overly impressed with the bolt-on acquisitions AbbVie has paid for in recent years; the $21bn it spent acquiring Pharmacyclics and its lymphoma treatment Imbruvica was seen

Ex-Pharmacyclics CEO invests $25m in Summit

Ex-Pharmacyclics CEO invests $25m in Summit Bob Duggan. Duggan was chief executive and president of Pharmacyclics when it was sold to AbbVie for $21bn in 2015, immediately catapulting him into the ranks of biotech billionaires, and Summit ... The heady valuation of the Pharmacyclics deal was

Lilly drops Hanmi-partnered arthritis drug

Lilly drops Hanmi-partnered arthritis drug The first BTK inhibitor to reach the market was Johnson &Johnson (J&J) and Pharmacyclics' Imbruvica (ibrutinib), but this has been introduced initially for blood cancers including chronic lymphocytic leukaemia (CLL) ... Meanwhile, Pharmacyclics (now part

Deal Watch March 2017

Deal Watch March 2017 name. (Abexinostat was formerly in development by Pharmacyclics (now owned by AbbVie) and Servier.) Both ACAT-1 (for which Xynomic paid $1.2m upfront with another $59m in potential milestones) and

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...

Infographics